micro 2

Acne: overview
  • Acne is a superficial skin infection/inflammatory condition centered around hair follicles and sebaceous glands.

  • Key lesion types:

    • Whitehead: pore closed, pus accumulation.

    • Blackhead: pore open, thick sebum/oxidized material at the surface.

    • Cystic acne: deeper infection with surrounding inflammation; squeezing causes rupture into surrounding tissue and potential scarring.

  • Primary organism in typical acne: Propionibacterium acnes (P. acnes).

  • Management (general): regular gentle cleansing; exfoliating/antibacterial cleansers with benzoyl peroxide to reduce organism load; avoid squeezing to prevent spread and cystic progression.

  • When to consider antibiotics: if widespread P. acnes proliferation with inflammation persists, topical antibiotics may be used to reduce organism load; avoid self-extraction.

Anatomy and progression
  • Most acne is superficial and centered at or just below the keratinized layer of the epidermis; superficial infections start in the epidermis or dermal-epidermal junction.

  • Boil/furuncle vs carbuncle involves more tissue: typically 2−62-6 follicles for a furuncle; >6>6 follicles for a carbuncle.

Boils (furuncle/carbuncle)
  • Causative organism: Staphylococcus aureus (often yellow/“golden” pus with a brassy tint; AU = gold).

  • Boil characteristics: large, purulent lesions that are painful, often well into the dermis/subcutaneous tissue; purulent drainage is key.

  • Diagnosis: clinical appearance; sterile drainage sample for Gram stain and culture (to confirm cocci in clusters for Staph aureus).

  • MRSA note: MRSA = Staphylococcus aureus with antibiotic resistance; not all Staph aureus are MRSA. If methicillin kills the organism, beta-lactams can be used; if MRSA resistant, alternatives are needed (sometimes IV antibiotics such as vancomycin in severe cases).

  • Treatment strategy:

    • Drainage of the boil (sterile technique).

    • Antibiotics (topical for minor cases; oral or IV for more severe cases; MRSA may require non-beta-lactam options).

    • Education: monitor for fever, spreading redness, deep pain, or non-resolution; hospital admission only if systemic involvement.

  • MRSA in the bloodstream is especially dangerous; invasive MRSA has higher mortality risk; prevalence has increased in the past decades.

Impetigo
  • Very superficial infection; honey-colored crusts around the mouth/face, can extend to neck/body.

  • Common causes: Staphylococcus aureus or Streptococcus pyogenes (group A Streptococcus).

  • Diagnosis: Gram stain from lesion swab (cocci in clusters for Staph; cocci in chains for Strep).

  • Treatment: topical antibiotics; emphasize hygiene to prevent spread (schools/daycares, etc.).

Staphylococcal Scalded Skin Syndrome (SSSS)
  • Also called Ritter disease; mostly affects newborns/infants.

  • Etiology: Staphylococcus aureus producing exfoliative toxins Eta and EtB; causes massive epidermal detachment within the keratinized layer (desquamation) but generally no deep tissue infection.

  • Distinct from SJS/TEN: SSSS splits within the epidermis (keratinized layer); SJS/TEN involves the dermis-epidermis junction and can be life-threatening.

  • Management: antibiotics to eradicate toxin-producing Staph; strict hand hygiene; supportive care; usually heals without scarring.

Cellulitis
  • Definition: infection of the dermis and subcutaneous tissue; may spread from a skin break or puncture wound.

  • Hallmarks: painful, red, warm, swollen skin with rapid progression; often shows lymphangitis (tracking lines) and regional lymph node swelling.

  • Common causative organisms:

    • Staphylococcus aureus

    • Streptococcus pyogenes (group A strep)

    • Other scenarios: animal bites can introduce Pasteurella multocida or Bartonella henselae (gram-negative rods); these are important to consider with animal exposure.

  • Diagnosis: Gram stain/culture from drained tissue; look for gram-positive cocci in clusters (Staph) or chains (Strep); in animal bite cases, expect gram-negative rods.

  • Treatment: systemic antibiotics (oral or IV); topical antibiotics are not sufficient due to depth of infection; imaging or cultures may be needed if severe or spreading.

  • Fungal cellulitis is rare; usually treated differently (antifungal therapy).

Implications and quick comparisons
  • Acne vs boils vs impetigo vs SSSS vs cellulitis: depth of infection and causative organism drive management and prognosis.

  • Key diagnostic cues:

    • Acne: superficial, comedones with possible inflammation.

    • Boil: localized, purulent, larger and deeper infection; golden pus; may require drainage.

    • Impetigo: honey-colored crusts on face, superficial; Gram stain to differentiate Staph vs Strep.

    • SSSS: widespread desquamation in infants; toxin-mediated, epidermal split within keratinized layer.

    • Cellulitis: dermal/subcutaneous infection with rapid spread and lymphangitis; often Staph/Strep; consider animal-bite organisms.

Quick reference rules for exam recall
  • Furuncle vs carbuncle sizes: 2−62-6 follicles vs >6>6 follicles.

  • MRSA concept: all MRSA are Staphylococcus aureus, but not all Staph aureus are MRSA; resistance guides antibiotic choice.

  • P. acnes is the typical skin commensal involved in acne; reducing its numbers helps with acne management.

  • Honey-colored crusts strongly suggest impetigo; Gram stain helps distinguish Staph vs Strep in impetigo.

  • SSSS toxins (Eta/EtB) cause epidermal split within the keratinized layer; not necessarily MRSA; treat with antibiotics and supportive care.

  • Cellulitis requires systemic antibiotics; depth (dermis/subcutaneous) differentiates it from epidermal infections.

Key numbers to remember
  • Boil follicle involvement: 2−62-6 follicles; carbuncle: >6>6 follicles.

  • Invasive MRSA mortality impact: extmortality→exthighwithbloodstreaminvolvement;approximatehistoricdataaround20%.ext{mortality} \rightarrow ext{high with bloodstream involvement; approximate historic data around }20\%.

  • Invasive MRSA incidence: about 10510^5 cases per year in the US (approx. 100,000).

  • Treatment durations: some antibiotics are given for short courses; severe cases may require hospital-based IV therapy for several days, e.g., 33 days or more depending on severity.

Notes on lab tests and timing
  • Gram stain results: typically within 1010 minutes to 11 hour.

  • Culture results: usually around 4848 hours.

  • Culture helps confirm organism and guide antibiotic choice, especially for boils and cellulitis.